Neogen Corporation stock, medical equipment

Neogen Corporation stock gains 2.03 percent as earnings beat estimates

Published on 09/24/2026 at 16:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Neogen Corporation stock traded at USD 13.85 on September 24, 2026, after fiscal fourth-quarter adjusted EPS reached USD 0.09. Investor Day follows October 7.

Neogen Corporation stock,  medical equipment,  earnings,  Investor Day,  Nasdaq, Illustration mit AI erstellt.
Neogen Corporation stock, medical equipment, earnings, Investor Day, Nasdaq, Illustration mit AI erstellt.

Neogen Corporation stock was trading at USD 13.85 on Nasdaq on September 24, 2026, up 2.03 percent from the previous close of USD 13.57. The move follows fiscal fourth-quarter results in which adjusted EPS reached USD 0.09, above the USD 0.05 estimate, while revenue totaled USD 225.3 million.

Earnings beat the estimate

Investing.com reported on September 16, 2026, that Neogen exceeded Wall Street expectations in fiscal fourth quarter 2026. Revenue of USD 225.3 million compared with the USD 212.52 million estimate, a difference of USD 12.78 million, while core growth reached 4.3 percent and food safety sales increased 5.8 percent on a core basis.

The operating picture remains uneven. Standardized quarterly data show revenue of USD 225.3 million and operating profit of USD 3.1 million for the quarter ended May 31, 2026, while net income was negative USD 11.3 million. That combination makes the next report important for judging whether revenue growth is translating into earnings.

Two October dates matter

Yahoo Finance reported on September 15, 2026, that Neogen will release first-quarter results after the market close on October 6, 2026. The earnings call is scheduled for 4:30 p.m. ET, giving investors a defined checkpoint for the companys new fiscal year.

A second date follows immediately. In its September 8, 2026 release, Neogen said its Investor Day will take place on October 7, 2026, at 9:00 a.m. ET in New York City. Management plans to discuss commercial execution, innovation and operational performance, so the event could add detail around the path to profitable growth.

Analyst target reaches USD 14

Investing.com reported that Piper Sandler upgraded Neogen to Overweight and raised its price target from USD 13.00 to USD 14.00. The target is USD 0.15 above the September 24 intraday price, while the companys market capitalization stood at USD 3,019,181,570.

Neogen develops food and animal safety products across its Food Safety and Animal Safety segments. Its near-term valuation now rests on whether the October results and Investor Day support the stronger operating trend shown by the fiscal fourth-quarter comparison.

Neogen stock trades near its yearly high

Neogen stock was trading at USD 13.85 on Nasdaq on September 24, 2026, with a session high of USD 14.01 and a session low of USD 13.48. The 52-week range was USD 5.10 to USD 14.26, placing the intraday price USD 0.41 below the yearly high.

Neogen Corporation market data

  • Company: Neogen Corporation
  • Ticker: NEOG
  • Trading venue: Nasdaq
  • Price as of September 24, 2026, 10:23 a.m. ET: USD 13.85
  • Market capitalization: USD 3,019,181,570 as of September 24, 2026
  • 52-week range: USD 5.10-14.26 as of September 24, 2026
  • Sector / Industry: Medical Equipment, Supplies and Distribution
  • Next earnings date: October 6, 2026

Disclaimer...

en | boerse | 70178159 |